Abstract Abrus precatorius is highly regarded as a universal panacea in the herbal medicine with diverse pharmacological activity spectra. This experimental study on the mechanism of the anticancer activity of A. precatorius leaf extracts, may offer new evidence for A. precatorius in the treatment of breast cancer in clinical practice. Cell death was determined by using MTT assay. Further analyses were carried out by doing DNA laddering, PARP cleavage, FACS, semi-quantitative RT-PCR and detection of cellular reactive oxygen species (ROS) by DCFDA assay. A. precatorius showed very striking inhibition on MDA-MB-231 cells. MTT assay showed more than 75 % inhibition of the cells and treated cells indicated visible laddering pattern with thick compact band. PARP cleavage produced 89 kDa cleavage product which was associated with apoptosis. Flow cytometer exhibited a sub-G0/G1 peak as an indicative of apoptosis. mRNA expression level of apoptosis-related genes p21 and p53 was markedly increased in cells treated with the extract as compared to control. The up-regulation of p21 and p53 may be the molecular mechanisms by which A. precatorius extract which induces apoptosis. An increase in the concentration of A. precatorius extract does not generate ROS, instead it reduces ROS formation in MDA-MB-231 cells, as evident from the shift in fluorescence below untreated control. This is the first report showing that A. precatorius leaf extract exhibits a growth inhibitory effect by induction of apoptosis in MDA-MB-231 cells. Our results contribute towards validation of the A. precatorius extract as a potentially effective chemopreventive or therapeutic agent against breast cancer.
Introduction
Cancer is one of the most dreaded diseases. It is estimated that by 2030, 26.4 million people a year may be diagnosed with cancer and 17 million people will die from it (World Health Organization 2010). Among cancers, breast cancer is the most commonly diagnosed cancer and is a leading cause of mortality among females worldwide, with 23 % (1.38 million) of the total new cancer cases and 14 % (458,400) of the total cancer deaths recorded in 2008 (Source; GLOBOCAN 2008) . It is estimated that half of the breast cancer cases and 60 % deaths due to cancer have been predicted to occur in economically developing countries (Jemal et al. 2011) . Breast cancer, like many other cancers, tends to metastasize to other parts of the body, preferably to the lungs and bones (Solomayer et al. 2000) . This process of neoplastic transformation, progression and metastasis involve alterations of normal apoptotic pathway (Bold et al. 1997) . Apoptosis is a physiological cell suicide program critical to development and tissue homeostasis. Abnormal apoptosis is associated with a wide variety of human diseases such as cancer, auto-immune disease and neurodegenerative diseases (Joaquin and Gollapudi 2001) . Hence the prerequisite for successful treatment of breast cancer is the susceptibility of the cancer cells to apoptosis (Sarath et al. 2007 ). Despite significant advances in the treatment for breast cancer, many patients suffer a systemic relapse. Therefore, there is a need to identify novel anticancer agents that induce apoptosis and to develop complementary and/or alternative treatments for the treatment of breast cancer and to significantly decrease obnoxious side effects (Norton 1999) . Natural phytochemicals isolated from medicinal plants have gained significant recognition in the potential management of several human clinical conditions, including cancer (Mehta et al. 2010) . There are more than 270,000 higher plants existing on this planet. India has one of the richest plant medical traditions in the world and around 25,000 effective plant-based formulations used in ethanobotanical communities in India. But only a small portion has been explored phytochemically (Helton 1996) . Therefore, the search for alternative drugs that are both effective and non-toxic in the treatment of cancers is an important research line (Tang et al. 2003) . In fact, increased efforts are being made to isolate bioactive products from medicinal plants for their possible utility in cancer treatment (Kinghorn et al. 2003) . The mechanisms of tumor prevention by natural phytochemicals range from the inhibition of genotoxic effects, increased antioxidants, inhibition of proteases, anti-inflammatory activity, cell proliferation, protection of intracellular communications to modulate apoptosis and signal transduction pathways (Soobrattee et al. 2006) . Many dietary supplements and plant-derived products are shown to be promising anti-cancer therapeutic agents and are now being assessed in pre-clinical and clinical studies (Cragg and Newman 2005) .
Abrus precatorius belongs to the family (Fabaceae), popularly known as Crab's eye, Indian liquorice, Jequirity, Rosary pea. It is originally native to India, but now commonly distributed throughout tropical and subtropical regions of the world (Naik 1998) . People consume leaves of A. precatorius by chewing (or in tea) while the seeds contain a toxin called abrin which is a strong inhibitor of protein synthesis and lethal even at relatively low doses (0.1-1 lg/kg). A. precatorius extracts have been receiving attention as anticancer agents as it has been shown that various phytochemicals from A. precatorius have the property to induce apoptosis on various types of cancers (Hickman 1992) . Several preliminary reports have documented that A. precatorius extract shows diverse pharmacological activity spectra especially, antitumoral (Hegde et al. 1991; Reddy and Sirsi 1969; Siddiqi et al. 2001) , mitogenic (Kaufman and McPherson 1975) , antifertility (Kamboj and Dhawan 1982) , immunopotentiating (Ramnath et al. 2002) , antimicrobial (Adelowotan et al. 2008) , immunostimulant activity (Bhutia et al. 2009 ), antianaphylactic activity (Taur and Patil 2011) , and anti-inflammatory activity (Anam 2001) . In this study, we have explored the cytotoxic effect of leaf extracts from A. precatorius on human metastatic breast cancer cell line MDA-MB-231, and provide a rationale for using A. precatorius as a therapeutic agent against breast cancer.
Materials and methods

Plant materials
Fresh, disease free leaves of the A. precatorius were collected from Danvantrivanna, Jnanabharathi campus Bangalore, Karnataka, in March and May, washed thoroughly 2-3 times with tap water and once with sterile distilled water, shade dried then powdered and used for extraction (Fabrican and Farnsworth 2001 ). An authenticated voucher specimen of the plant is deposited in the herbarium of Molecular Diagnostic Laboratory, Department of Microbiology and Biotechnology, Bangalore University, Bangalore.
Preparation of plant extract
Aqueous crude leaf extracts of plants were prepared according to Sateesh (1998) . Dried plant sample was grinded to fine powder in mixer-grinder and sieved. The powder was suspended in double distilled water at the rate of 5 gms in 30 ml, sonicated for 15 min and mixed with magnetic stirrer for overnight. Each extract was passed through two layered cheese cloth (Garg et al. 2007) . The filtrate was then centrifuged at 5,000 rpm for 30 min. Lyophylization of the mother solution was done with a Speedvac (Savant Speedvac SC100 Centrifugal Evaporator, USA). Lyophilized aqueous extract was dissolved in PBS (sterile) to a stock concentration of 50 mg/ml and then passed through a 0.2 lm filter (Sartorius Stedim) for sterilization and was then used for cytotoxicity assays.
Cell lines and culturing of cells
Human breast cancer cell line MDA-MB-231 was procured from Indian Institute of Science (IISc), Bangalore (India). Cells were maintained in Dulbecco's Modified Eagle's medium (DMEM) with 10 % FBS, 100 U/ml penicillin, and 100 lg/ml streptomycin, in a humidified atmosphere of 95 % air and 5 % CO 2 at 37°C. Once the cells had covered about 80 % of the surface, they were trypsinized and the titre was adjusted using haematocytometer for antiproliferative and cytotoxicity measurements.
Analyses of cell viability
The effect of aqueous extract of A. precatorius on the viability of cells was determined using the standard colorimetric MTT assay using the 3-(4,5-dimethylthiazol-2-yl)-2,5-dimethyl tetrazolium bromide dye (Sigma, St. Louis, MO, USA), according to Carmichael et al. (1987) . This assay is based on the reduction of MTT by the mitochondrial dehydrogenase of intact cells to a purple formazan product (Mosmann 1983 ). MDA-MB-231 cells (5 9 10 3 cells/well) were seeded to 96-well microtiter plates (Falcon, BectonDickinson, Franklin Lakes, NJ, USA). After 24 h of plating, cells were serum starved for 24 h. Respective concentrations of A. precatorius extracts were added to serum free medium and the assay was terminated after 48 h. Medium was removed and 200 ll DMSO was added and the amount of formazan formed was measured at 595 nm on a Model 680 Microplate Reader (Bio-Rad Laboratories, Inc., Hercules, CA, USA).
DNA fragmentation by agarose gel electrophoresis DNA fragmentation was analyzed by the gel electrophoresis method according to Herrmann et al. (1994) . MDA-MB-231 Cells (5 9 10 6 cells) were incubated with 600 lg/ml of the A. precatorius extract for 12 h at 37°C. After treatment, cells were washed in cold PBS and lysed in a buffer containing 50 mM Tris-HCl (pH 8.0), 1 mM EDTA, 0.2 % Triton X 100 for 20 min at 4°C. After centrifugation at 14,0009g for 15 min, the supernatant was treated with proteinase K (0.5 mg/ml) and 1 % SDS for 1 h at 50°C. DNA was extracted twice with phenol and precipitated with 140 mM NaCl and 2 vol. of ethanol at -20°C overnight. DNA precipitates were washed twice in 70 % ethanol, dissolved in TE buffer, and treated for 1 h at 37°C with RNaseA (Peng et al. 2009 ). Finally, DNA preparations were electrophoresed in 1 % agarose gels, stained with ethidium bromide and visualized under UV light.
Western blot analysis of cell cycle regulatory protein-poly-ADP ribose polymerase (PARP) cleavage assay to detect apoptosis For immunoblot analysis, total cell lysates were collected in lysis buffer [50 mM HEPES-KOH, pH 7.5, 1 % Triton X-100, 150 mM NaCl, and protease inhibitor cocktail (Roche, New York, NY, USA)]. The extracts were centrifuged at 12,000 rpm for 20 min, and then the clear supernatant was collected. The protein content was determined by Bradford method (Bradford 1976) . Proteins (100 lg) were separated on 10 % sodium dodecyl sulphate (SDS)-polyacrylamide gel and electro-transferred to polyvinyldene fluoride (PVDF) membrane (Immunobilon-P, 0.45 mm; Millipore, Billerica, MA, USA). The membranes were blocked with 5 % (w/v) non fat dry milk and then probed with a relevant antibody (PARP at 1:1,000 dilution) for 12 h at 4°C followed by detection using peroxidase-conjugated secondary antibodies (Santa Cruz Biotech, Santa Cruz, CA, USA). The membranes were then washed 4 times with TrisBuffered Saline and Tween 20 (TBST), followed by detection using chemiluminescence ECL kit (GE Healthcare Biosciences, Piscataway, NJ, USA) and exposed to an X-ray film (Kodak, Rochester, NY, USA). For equal loading of proteins, the membrane was probed with appropriate loading controls. b-Actin was used as loading control (Zhou et al. 2010 ).
Cell cycle analysis by fluorescence-activated cell sorter (FACS) MDA-MB-231 cells were incubated at 5 9 10 6 cells/ well in 6-well plates, treated with A. precatorius extract for 48 h at 37°C. The detached and attached cells were harvested and fixed in 70 % ice-cold methanol at -20°C overnight. After fixation, cells were washed with PBS, resuspended in 1 ml PBS containing 1 mg/ml RNase (Sigma, St. Louis, MO, USA), and 50 lg/ml propidium iodide (Sigma, St. Louis, MO, USA), and incubated at 37°C for 30 min in the dark (Ping et al. 2006 ). Samples of 10,000 cells were then analyzed for DNA content and cell cycle phase distributions by using FACS-Calibur and Cell-Quest software (Becton-Dickinson Biosciences).
Determination of the expression level of apoptosisrelated genes (p21 and p53) by semi-quantitative reverse transcription polymerase chain reaction (RT-PCR)
Abrus precatorius extract treated cells were washed with PBS. Total RNA was isolated from MDA-MB-231 cells by Trizol Ò reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. After extraction, total RNA was measured at 260 nm for quantification. Before performing the RT reaction, total RNA was adjusted to the final concentration of 1 lg/lL, and RNA was treated with 10 -5 U deoxyribonuclease I (DNase I) (Invitrogen, Carlsbad, CA, USA) for 30 min at 37°C. DNase-I treated RNA was reverse transcribed by ImProm-IITM Reverse Transcription System (Promega, Madison, WI, USA) with oligo(dT)17 primer following the manufacturer's protocol. For amplification of the cDNA, each desired DNA fragment was amplified for 35-40 cycles using each gene-specific preimer pair (Table 1 ). All PCR reactions were done at non-saturating cycle numbers, which were determined for each gene. The optimized PCR amplification program comprised an initial denaturation step at 94°C for 2 min followed by denaturation at 94°C for 45 s, annealing at 56°C for 1 min, extension at 72°C for 2 min and final extension step at 72°C for 10 min (Lee et al. 2009a, b) . RPL35a (a ribosomal protein coding RNA) was used as an internal control for integrity and equal amount of cDNA used in each PCR reaction. Doxorubicin (Dox) 20 lM was used as a positive control (Rethy et al. 2008) . PCR products were analyzed on 2 % agarose gels.
The percentage of cell population generating ROS was determined by flow cytometry analysis. The detection of ROS generation by flow cytometric analysis was performed by incubating MDA-MB-231 cells with the extract (600 lg/ml) for 30 min in serum free conditions. The cells were harvested by trypsinization and a single cell suspension of 1 9 10 6 cells/ml was made. The cells were then treated with 1 lM DCF-DA solution (in DMSO) for 15-20 min in dark at room temperature. The distribution of DCF-DA stained MDA-MB-231 cells were determined by using FACSCalibur and Cell-Quest software (Becton-Dickinson Biosciences) in the FL-1 channel as reported previously (Ju et al. 2007 ). (Fig. 1a) . Microscopic studies show significant morphological changes such as shrinking of cytoplasm, condensation of nucleus and formation of membrane bound vesicles (apoptotic bodies) in treated MDA-MB-231 cells (1 9 10 6 cells/ml) with 600 lg/ml of the aqueous extract of A. precarious for 48 h as compared to control cells (Fig. 1b) .
Abrus precatorius extract induces significant DNA fragmentation in MDA-MB-231 cells Specific DNA cleavage and formation of DNA fragments of oligonucleosomal size (180-200 bp) is the hallmark of apoptosis in many cell types. This becomes evident in electrophoresis analysis by agarose gel electrophoresis (Enari et al. 1998 ). To elucidate whether the A. precatorius extract inhibits MDA-MB-231 cell proliferation through induction of apoptosis, cell death was examined by DNA fragmentation for 12 h treatment. Supernatants of control and apoptotic cell cultures were analyzed by agarose gel electrophoresis in the presence of marker 100 bp DNA ladder. Significant apoptosis was seen in the treated cultures with visible laddered pattern while thick compact band was seen in the control (Fig. 2) .
Western blotting clearly demonstrated a dose and time dependent inactivation of PARP in A. precatorius extract treated MDA-MB-231 cells Apoptosis involves various initiator and executor caspases. Among the executor caspases, caspase-3 has been reported to cleave a number of substrates including PARP which acts in response to DNA strand breaks leading to apoptosis (Nicholson and Thornberry 1997) . PARP cleavage occurs at Asp216 to generate 83 and 24 kDa apoptotic fragments during apoptosis (Soldani and Scovassi 2002 (Fig. 3) .
Effect of A. precatorius extract on cell cycle distribution by flow cytometry
Cell cycle control is a major regulatory mechanism of cell growth. Blockade of the cell cycle is considered as an effective strategy for the development of novel cancer therapies (McDonald and Deiry 2000) . To gain insights into the mechanism by which cell reduction is achieved, we investigated the effect on cell cycle distribution by FACS analysis, and the results are summarized in (Fig. 4 ). An alteration in the percentage of cells in each stage of the cell cycle: G0/G1, S and G2/M, as compared to the control was observed. The results showed the increase of sub G0/G1 phase (apoptotic peak) of cell cycle in dose and time-dependent manner indicating that A. precatorius had a prominent ability to induce cell cycle arrest at G0/G1 phase and apoptosis in MDA-MB-231 cells (Fig. 4) . The p53 gene codes for a protein that plays a key role in tumor suppression and cell cycle regulation. The loss of this protein due to mutation is a primary event in the formation of many types of leukemia's, breast, colon, lung and liver cancer (Haupt et al. 2003) . The p21 is activated by p53 protein, and an increased level of p21 is associated with cyclin containing complexes with decreasing cyclin-dependent activity in damaged cells destined to apoptosis (Harper et al. 1993) . Previous reports also show marked increase in the expression of p53 at a 100 lg/ml concentration of A. precatorius seed extract. Also in the present study even control MDA-MB-231 cells did not exhibit expression of p53, but in the A. precatorius extract treated cells mRNA expression level was markedly increased and the mRNA expression level of p21 was also increased significantly. Expression of apoptosisrelated genes, p21 and p53, was evaluated by RT-PCR. Control MDA-MB-231 cells did not exhibit their expression, but in the A. precatorius extract treated cells mRNA expression levels were markedly increased (Fig. 5 ).
ROS were not generated in A. precatorius extract treated cells, instead A. precatorius extract reduces ROS formation in MDA-MB-231 cells
Anticancer phytochemicals have been shown to suppress or block cancer proliferation by acting as antiproliferative agents or antioxidants (Chang et al. 2008; Lee et al. 2009a, b) . Apoptosis is carried out by a multistage chain of reactions in which ROS acts as trigger and essential mediator (Kerr et al. 1994) . ROS such as super-oxide anion (O 2 -) and its reduced product hydrogen peroxide (H 2 O 2 ) have been considered as cytotoxic by products of cellular metabolism, and the accumulation of ROS in cells may promote cell death. The dihydro-analogues fluorescent probe, 2 0 ,7 0 -Dichlorofluorescein diacetate (DCF-DA) is commonly used to detect the generation of cellular reactive oxygen species (ROS) (Keston and Brandt 1965) . Cell permeable DCF-DA can be oxidized by cellular ROS to generate fluorescent compound, Dichlorofluorescein having emission spectrum maxima at 525 nm (Esposti 2002) . Cells treated with A. precatorius extract, were stained with ROSspecific dyes, 2 0 ,7 0 -Dichlorofluorescein diacetate (DCF-DA). Altogether, these results indicate that the increasing concentration of A. precatorius extract does not generate ROS. Instead it reduces ROS levels in MDA-MB-231 cells, as evident from the shift in fluorescence in comparison to the control (Fig. 6 ).
Discussion
The results of the present study showed that the extract of Abrus precatorius had a marked inhibitory effect on the proliferation of breast cancer cell line (MDA-MB-231). A. precatorius extracts markedly reduced cell viability in a concentration dependent manner. Previous preliminary studies on various cancer cell lines showed that various phytocompounds isolated from A. precatorius demonstrated marked inhibitory effects and have properties to induce apoptosis on various types of cancers (Hickman 1992) . Glycyrrhizin, a triterpenoid saponins isolated from A. precatorius leaves and roots, induce apoptosis in many cell types including human hepatoma (HLE), promyelotic leukemia (HL-60) and stomach cancer (KATO III) and Kaposi sarcoma associated herpes virus-infected cells (Hibasami et al. 2005 (Hibasami et al. , 2006 . The molecular study results showed suppression of cell growth induced by A. precatorius extract is due to induction of apoptosis rather than the inhibition of cell proliferation. In the present work various molecular events responsible for cytotoxicity were also studied. Significant apoptosis was seen in the treated cultures with visible ladder pattern while a thick compact band was seen in the control. Studies have shown that some proteins, including Abrin (ABR), purified from A. precatorius, induce apoptosis in various types of cancer cells (Shih et al. 2001; Narayanan et al. 2004) . Also Abrus lectins are considered as potential anticancer agents due to their apoptosis-inducing activity (Lin et al. 1970) . Abrins are more toxic to tumour cells than normal cells (Harborne et al. 1999) . Not many studies have been done on the cytotoxic effect of A. precatorius on cancerous cells hence, molecular level investigation needs to be carried out. Results from immunoblot analysis using PARP antibody, recognizes the cleavage of PARP in A. precatorius treated MDA-MB-231 cells (Fig. 3) . This confirmed A. precatorius induces apoptosis by cleaving cell cycle regulatory proteinpoly-ADP ribose polymerase (PARP). Cell cycle analysis by flow cytometer exhibited a sub-G0/G1 peak in A. precatorius treated MDA-MB-231 cells. As compared to control, treated cells showed a significant increase of cells in sub-G1 phase, indicating the occurrence of an apoptotic event. The p53, known as guardian of human genome is a gene that codes for a protein that regulates the cell cycle and hence functions as a tumor suppressor. In cancerous cells, the expression of p53 is much suppressed (Bhutia et al. 2009 ). The p53 tumor suppressor gene is a cell cycle regulator able to induce cell cycle arrest to allow DNA repair or apoptosis (Vogelstein and Kinzler 1992) . In the present study control MDA-MB-231 cells did not exhibit expression of p53, but in the A. precatorius extract treated cells mRNA expression levels were markedly increased and the mRNA expression level of p21 was also increased significantly. This up-regulation of p21 and p53 may be the molecular mechanisms by which A. precatorius extract induces apoptosis, however, further definitive studies are needed. Results from DCFDA assay showed increase in the concentration of A. precatorius extract does not generate ROS, instead it reduces ROS formation in MDA-MB-231 cells, as evident from the shift in fluorescence with respect to control. This showed reactive oxygen species play no role in apoptosis induction in MDA-MB-231 cells.
In conclusion, the present study clearly demonstrated the potential anticancer activity of A. precatorius extract against human breast cancer cell line MDA-MB-231. Also the results from our molecular studies clearly showed that the cell death was by apoptosis. A. precatorius extract have been reported to induce proliferation inhibition and cell death in various types of cancers (Reddy and Sirsi 1969; Hegde et al. 1991; Hickman 1992; Siddiqi et al. 2001) . As apoptosis has become a promising therapeutic target in cancer research, these results confirm the potential of A. precatorius extract as an agent of chemotherapeutic and cytotoxic activity in human breast cancer cells. Phytochemical analysis and bioassay-directed isolation of bioactive components from the aqueous extract of the leaves of A. precatorius need to be done, and more detailed studies are required to determine the exact mechanism(s) of action behind the cytotoxic and apoptotic activities of A. precatorius extract.
